Article
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma
1 Dec 2023
Abstract excerpt
Glaucoma, a chronic neurodegenerative disease, is a leading cause of age-related blindness worldwide and characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons. Previously, we developed a novel epigenetic rejuvenation therapy, based on the expression of the three transcription factors Oct4, Sox2, and Klf4 (OSK), which safely rejuvenates RGCs without altering cell identity in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
